Histochemical Characteristics on Minimodeling-Based Bone Formation Induced by Anabolic Drugs for Osteoporotic Treatment.
Takanobu Yamamoto,Tomoka Hasegawa,Paulo Henrique Luiz de Fraitas,Hiromi Hongo,Shushan Zhao,Tsuneyuki Yamamoto,Alireza Nasoori,Miki Abe,Haruhi Maruoka,Kosei Kubota,Yasuhito Morimoto,Masanobu Haraguchi,Tomohiro Shimizu,Masahiko Takahata,Norimasa Iwasaki,Minqi Li,Norio Amizuka
DOI: https://doi.org/10.2220/biomedres.42.161
2021-01-01
Biomedical Research
Abstract:Modeling, the changes of bone size and shape, often takes place at the developmental stages, whereas bone remodeling-replacing old bone with new bone-predominantly occurs in adults. Unlike bone remodeling, bone formation induced by modeling i.e., minimodeling (microscopic modeling in cancellous bone) is independent of osteoclastic bone resorption. Although recently-developed drugs for osteoporotic treatment could induce minimodeling-based bone formation in addition to remodeling-based bone formation, few reports have demonstrated the histological aspects of minimodeling-based bone formation. After administration of eldecalcitol or romosozumab, unlike teriparatide treatment, mature osteoblasts formed new bone by minimodeling, without developing thick preosteoblastic layers. The histological characteristics of minimodeling-based bone formation is quite different from remodeling, as it is not related to osteoclastic bone resorption, resulting in convex-shaped new bone and smooth cement lines called arrest lines. In this review, we will show histological properties of minimodeling-based bone formation by osteoporotic drugs.